Bio-Rad Laboratories, Inc. Class B Common Stock - Bilanço (NYSE:BIO-B) | MetaTrader

Tam grafiği aç

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

Toplam varlıklar 12.97 B17.78 B13.5 B12.3 B9.36 B10.58 B Toplam yükümlülükler 3.09 B4.11 B3.89 B3.56 B2.79 B3.12 B Toplam özsermaye 9.88 B13.67 B9.62 B8.74 B6.57 B7.45 B Toplam yükümlülükler ve hissedarların özsermayesi 12.97 B17.78 B13.5 B12.3 B9.36 B10.58 B Toplam borç ———1.2 B1.2 B1.2 B Net borç ———1.2 B1.2 B-339 M

Haberler

Bio-Rad Laboratories, Inc. (BIO) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Stocks Settle Mixed as Iran War Remains Unresolved

Stocks Pressured by a Rebound in Crude Prices and Bond Yields

Stocks Mixed as Crude Oil Prices and Bond Yields Fall

UnitedHealth ve Regeneron düştü; Dominion Energy ve Delta yükseldi

Three ways the AI boom may fizzle and what happens to stocks next

Elliott Investment, Sartorius ve Bio-Rad’de hisse aldı

Elliott, Bio-Rad’da ’önemli’ hisse aldı - WSJ

Exclusive | Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad

Ariel Focus Fund Q1 2026 Performers And Detractors

Unlocking Bio-Rad (BIO) International Revenues: Trends, Surprises, and Prospects

Bio-Rad Laboratories hisseleri gelir tahminini düşürdü